Model Comparison Series: GPT-5.2
OpenAI dropped GPT-5.2 in December 2025. The update focused on three main areas: reasoning, coding, and long-document handling. It also claimed roughly 30% lower hallucination rates compared
OpenAI dropped GPT-5.2 in December 2025. The update focused on three main areas: reasoning, coding, and long-document handling. It also claimed roughly 30% lower hallucination rates compared
Web3 hacks cost $4.3B in 2025 alone. Here's the 2026 security stack every developer needs.
Remember when startups could get away with using a single database for everything? Those days are gone. In today's data-driven landscape, choosing the...
OpenAI just raised $110 billion in a single day. Is this the biggest AI bubble ever, or just the beginning?
🔥 This isn't just about AI ethics. It's a $30 billion standoff over who controls the future of warfare....
TSMC's Q2 2026 net profit soared 77.4% to a record NT$706.56 billion on $40.2 billion in revenue — the clearest proof yet that the AI boom is real, paid-for, and printing cash.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Developer documentation is the silent killer of product adoption. A 2025 study by the Developer Marketing Alliance found that 67% of developers will a...
Vera Therapeutics just won FDA accelerated approval for TRUTAKNA, the first dual BAFF/APRIL inhibitor for IgA nephropathy — priced at $425,000 a year. Here's why the two-target bet matters.
Feature Image: https://images.unsplash.com/photo-1648792940059-3b782a7b8b20?crop=entropy&cs=tinysrgb&fit=max&fm=jpg&ixid=M3w3ODQzODd8MHwxfHNlYXJj...
BREAKING NEWS — In a move that signals the pharmaceutical industry's full-scale embrace of artificial intelligence, Swiss healthcare giant Roche has ...